TACAHE

K052534 · Dalton Medical Corp. · ITI · Jan 27, 2006 · Physical Medicine

Device Facts

• Record ID: K052534
• Device Name: TACAHE
• Applicant: Dalton Medical Corp.
• Product Code: ITI · Physical Medicine
• Decision Date: Jan 27, 2006
• Decision: SESE
• Submission Type: Traditional
• Regulation: 21 CFR 890.3860
• Device Class: Class 2
• Attributes: Therapeutic

Intended Use

The intended use of the ELEXUS(PC-1450) is to provide mobility to persons limited to a seated position that are capable of operating a powered wheelchair.

Device Story

ELEXUS (PC-1450) is a powered wheelchair designed to provide mobility to individuals with limited physical ability to walk. Device operates via user-controlled interface allowing navigation in various environments. Intended for use by patients capable of operating powered mobility aids. Provides independent mobility; enhances quality of life by facilitating movement for seated users.

Clinical Evidence

Bench testing only.

Technological Characteristics

Powered wheelchair; class II device; product code ITI; regulation 890.3860.

Indications for Use

Indicated for persons limited to a seated position capable of operating a powered wheelchair.

Regulatory Classification

Identification

A powered wheelchair is a battery-operated device with wheels that is intended for medical purposes to provide mobility to persons restricted to a sitting position.

Submission Summary (Full Text)

{0}------------------------------------------------

Image /page/0/Picture/1 description: The image is a black and white logo for the U.S. Department of Health & Human Services. The logo features a stylized image of a bird with human profiles incorporated into its design. The bird is encircled by the text "DEPARTMENT OF HEALTH & HUMAN SERVICES USA" in a circular arrangement.

NOV - 6 2007

Food and Drug Administration 9200 Corporate Boulevard Rockville, Maryland 20850

Mr. Will Ridgway Sales Manager Dalton Medical Corporation 1103 Venture Ct. Carrollton, Texas 75006

Re: k052534

Trade/Device name: Tacahe Regulation Number: 890.3860 Regulation Name: Powered wheelchair Regulatory Class: II Product Code: ITI Dated: January 11, 2006 Received: January 12, 2006

Dear Mr. Ridgway:

This letter corrects our substantially equivalent letter of January 27, 2006.

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

{1}------------------------------------------------

## Page 2 -

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (sections 531-542 of the Act); 21 CFR 1000-1050.

This letter will allow you to continue marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at [phone]. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number [phone] or [phone] or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html

Sincerely yours,
Mark A. Milliron

Mark N. Melkerson Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health

Image /page/1/Picture/6 description: The image is a black and white circular logo or seal. The central element is the acronym 'FDA' in a bold, stylized font, with the word 'Centennial' written below it in a smaller font. Above the 'FDA' acronym, the years '1906 - 2006' are displayed, indicating a centennial celebration. The outer ring of the circle contains text, but it is difficult to read due to the image quality. There are also three stars below the word 'Centennial'.

Protecting and Promoting Public Health

{2}------------------------------------------------

## Indications for Use

The Children of the

K052534 510(k) Number (if known):

Device Name: ELEXUS(PC-1450)

Indications For Use:

The intended use of the ELEXUS(PC-1450) is to provide mobility to persons limited to a seated position that are capable of operating a powered wheelchair.

Prescription Use (Part 21 CFR 801 Subpart D) AND/OR

Over-The-Counter Use xx (21 CFR 807 Subpart C)

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NE-1 DF-1)

Concurrence of CDRH, Off ce of Device Evaluation (ODE)

2

(Division Sign-Off) (Division Sign-Ord) Restorative, and Neurological Londes

510(k) Number K052534

Page 1 of ____________________________________________________________________________________________________________________________________________________________________